CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Return
135.58%
This Quarter Return
+6.34%
1 Year Return
+135.58%
3 Year Return
+366.07%
5 Year Return
+793.68%
10 Year Return
–
AUM
$15B
AUM Growth
+$395M
(+2.7%)
Cap. Flow
-$29.7M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
374
New
86
Increased
129
Reduced
65
Closed
94
Top Buys
| 1 |
Monster Beverage
MNST
|
+$104M |
| 2 |
McKesson
MCK
|
+$98.8M |
| 3 |
American Express
AXP
|
+$95M |
| 4 |
Royal Caribbean
RCL
|
+$94.3M |
| 5 |
Constellation Brands
STZ
|
+$93.6M |
Top Sells
| 1 |
General Motors
GM
|
+$172M |
| 2 |
Boeing
BA
|
+$165M |
| 3 |
NBL
Noble Energy, Inc.
NBL
|
+$162M |
| 4 |
Procter & Gamble
PG
|
+$151M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$141M |
Sector Composition
| 1 | Healthcare | 22.76% |
| 2 | Consumer Discretionary | 15.86% |
| 3 | Technology | 15.37% |
| 4 | Industrials | 12.13% |
| 5 | Financials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Oramed Pharmaceuticals
ORMP
$98.8M
| $528K | ﹤0.01% |
+44,725
| New | +$528K |
|
277
Insmed
INSM
$30.8B
| $444K | ﹤0.01% |
+23,323
| New | +$444K |
|
|
FURX
278
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $363K | ﹤0.01% |
+4,170
| New | +$363K |
|
279
Cytokinetics
CYTK
$6.12B
| $312K | ﹤0.01% |
32,808
-107,259
| -77% | -$1.02M |
|
280
Galectin Therapeutics
GALT
$344M
| $261K | ﹤0.01% |
+17,026
| New | +$261K |
|
281
Acadia Pharmaceuticals
ACAD
$3.98B
| – | – |
-431,014
| Closed | -$10.8M |
|
282
Amgen
AMGN
$149B
| – | – |
-183,627
| Closed | -$20.9M |
|
283
American Tower
AMT
$91.3B
| – | – |
-155,825
| Closed | -$12.4M |
|
284
A.O. Smith
AOS
$10.2B
| – | – |
-2,298,912
| Closed | -$62M |
|
|
AVDL
285
Avadel Pharmaceuticals
AVDL
$1.5B
| – | – |
-58,132
| Closed | -$468K |
|
|
286
Boeing
BA
$163B
| – | – |
-1,209,311
| Closed | -$165M |
|
287
Best Buy
BBY
$15.9B
| – | – |
-253,432
| Closed | -$10.1M |
|
288
Bread Financial
BFH
$2.95B
| – | – |
-47,832
| Closed | -$10M |
|
289
Burlington
BURL
$16.8B
| – | – |
-541,223
| Closed | -$17.3M |
|
290
Crown Castle
CCI
$41.5B
| – | – |
-1,684,643
| Closed | -$124M |
|
291
Core Laboratories
CLB
$581M
| – | – |
-69,829
| Closed | -$13.3M |
|
292
Commault Systems
CVLT
$7.82B
| – | – |
-690,276
| Closed | -$51.7M |
|
293
Designer Brands
DBI
$225M
| – | – |
-876,581
| Closed | -$37.5M |
|
294
Delek US
DK
$1.68B
| – | – |
-677,435
| Closed | -$23.3M |
|
295
Euronet Worldwide
EEFT
$3.6B
| – | – |
-858,914
| Closed | -$41.1M |
|
296
Employers Holdings
EIG
$983M
| – | – |
-345,450
| Closed | -$10.9M |
|
297
Five Below
FIVE
$7.71B
| – | – |
-842,744
| Closed | -$36.4M |
|
298
Fossil Group
FOSL
$168M
| – | – |
-178,310
| Closed | -$21.4M |
|
299
GE Aerospace
GE
$299B
| – | – |
-5,409
| Closed | -$727K |
|
|
300
General Motors
GM
$55.7B
| – | – |
-4,219,930
| Closed | -$172M |
|